Literature DB >> 21490215

Calcium-permeable AMPA receptors are present in nucleus accumbens synapses after prolonged withdrawal from cocaine self-administration but not experimenter-administered cocaine.

James E McCutcheon1, Xiaoting Wang, Kuei Y Tseng, Marina E Wolf, Michela Marinelli.   

Abstract

Repeated noncontingent cocaine injections, which lead to behavioral sensitization, increase AMPA receptor (AMPAR) transmission in the rodent nucleus accumbens (NAc) in a withdrawal-dependent manner. On withdrawal days (WD) 10-21, this is attributable to upregulation of GluA1A2-containing AMPARs. However, synaptic incorporation of GluA2-lacking/Ca(2+)-permeable AMPARs (CP-AMPARs) was observed after longer withdrawal (WD35) from repeated noncontingent cocaine injections in young mice (Mameli et al., 2009). CP-AMPARs had previously been observed in NAc synapses only after prolonged (WD30-WD47) withdrawal from extended-access cocaine self-administration. Our goal was to determine whether rats receiving repeated noncontingent cocaine injections during adulthood similarly exhibit CP-AMPARs in the NAc after prolonged withdrawal. For comparison, we began by evaluating CP-AMPARs on WD35-WD49 after extended-access cocaine self-administration. Confirming our previous results, whole-cell recordings revealed inwardly rectifying AMPAR EPSCs, a hallmark of CP-AMPARs. This was observed in both core and shell. Next, we conducted the same analysis in adult rats treated with eight daily noncontingent cocaine injections and recorded on WD35-WD49. AMPAR EPSCs in core and shell did not show inward rectification and were insensitive to 1-naphthylacetylspermine (a selective antagonist of CP-AMPARs). Locomotor sensitization could still be demonstrated after this long withdrawal period, although the upregulation of GluA1A2-containing AMPARs observed at earlier withdrawal times was no longer detected. In conclusion, in adult rats, accumulation of synaptic CP-AMPARs in the NAc occurs after prolonged withdrawal from extended-access cocaine self-administration but not after prolonged withdrawal from noncontingent cocaine injections.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21490215      PMCID: PMC3157976          DOI: 10.1523/JNEUROSCI.0350-11.2011

Source DB:  PubMed          Journal:  J Neurosci        ISSN: 0270-6474            Impact factor:   6.167


  24 in total

1.  Cocaine-evoked synaptic plasticity: persistence in the VTA triggers adaptations in the NAc.

Authors:  Manuel Mameli; Briac Halbout; Cyril Creton; David Engblom; Jan Rodriguez Parkitna; Rainer Spanagel; Christian Lüscher
Journal:  Nat Neurosci       Date:  2009-07-13       Impact factor: 24.884

Review 2.  Age matters.

Authors:  James Edgar McCutcheon; Michela Marinelli
Journal:  Eur J Neurosci       Date:  2009-03       Impact factor: 3.386

3.  Cell surface AMPA receptors in the rat nucleus accumbens increase during cocaine withdrawal but internalize after cocaine challenge in association with altered activation of mitogen-activated protein kinases.

Authors:  Amy C Boudreau; Jeremy M Reimers; Michael Milovanovic; Marina E Wolf
Journal:  J Neurosci       Date:  2007-09-26       Impact factor: 6.167

4.  Signaling pathway adaptations and novel protein kinase A substrates related to behavioral sensitization to cocaine.

Authors:  Amy C Boudreau; Carrie R Ferrario; Marc J Glucksman; Marina E Wolf
Journal:  J Neurochem       Date:  2009-05-03       Impact factor: 5.372

5.  Recruitment of calcium-permeable AMPA receptors during synaptic potentiation is regulated by CaM-kinase I.

Authors:  Eric S Guire; Michael C Oh; Thomas R Soderling; Victor A Derkach
Journal:  J Neurosci       Date:  2008-06-04       Impact factor: 6.167

6.  Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period.

Authors:  M B Ghasemzadeh; C Mueller; P Vasudevan
Journal:  Neuroscience       Date:  2008-11-01       Impact factor: 3.590

7.  Formation of accumbens GluR2-lacking AMPA receptors mediates incubation of cocaine craving.

Authors:  Kelly L Conrad; Kuei Y Tseng; Jamie L Uejima; Jeremy M Reimers; Li-Jun Heng; Yavin Shaham; Michela Marinelli; Marina E Wolf
Journal:  Nature       Date:  2008-05-25       Impact factor: 49.962

8.  Cocaine experience controls bidirectional synaptic plasticity in the nucleus accumbens.

Authors:  Saïd Kourrich; Patrick E Rothwell; Jason R Klug; Mark J Thomas
Journal:  J Neurosci       Date:  2007-07-25       Impact factor: 6.167

9.  Renewed cocaine exposure produces transient alterations in nucleus accumbens AMPA receptor-mediated behavior.

Authors:  Ryan K Bachtell; David W Self
Journal:  J Neurosci       Date:  2008-11-26       Impact factor: 6.167

10.  Prolonged withdrawal from repeated noncontingent cocaine exposure increases NMDA receptor expression and ERK activity in the nucleus accumbens.

Authors:  Johanna Schumann; Rami Yaka
Journal:  J Neurosci       Date:  2009-05-27       Impact factor: 6.167

View more
  111 in total

1.  Alterations in AMPA receptor subunits and TARPs in the rat nucleus accumbens related to the formation of Ca²⁺-permeable AMPA receptors during the incubation of cocaine craving.

Authors:  Carrie R Ferrario; Jessica A Loweth; Mike Milovanovic; Kerstin A Ford; Gregorio L Galiñanes; Li-Jun Heng; Kuei Y Tseng; Marina E Wolf
Journal:  Neuropharmacology       Date:  2011-01-27       Impact factor: 5.250

2.  Effects of withdrawal from chronic escalating-dose binge cocaine on conditioned place preference to cocaine and striatal preproenkephalin mRNA in C57BL/6J mice.

Authors:  Yong Zhang; Stefan D Schlussman; Eduardo R Butelman; Ann Ho; Mary Jeanne Kreek
Journal:  Neuropharmacology       Date:  2012-04-04       Impact factor: 5.250

3.  Temporally dependent changes in cocaine-induced synaptic plasticity in the nucleus accumbens shell are reversed by D1-like dopamine receptor stimulation.

Authors:  Pavel I Ortinski; Fair M Vassoler; Gregory C Carlson; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2012-03-14       Impact factor: 7.853

4.  A-Kinase Anchoring Protein 150 (AKAP150) Promotes Cocaine Reinstatement by Increasing AMPA Receptor Transmission in the Accumbens Shell.

Authors:  Leonardo A Guercio; Mackenzie E Hofmann; Sarah E Swinford-Jackson; Julia S Sigman; Mathieu E Wimmer; Mark L Dell'Acqua; Heath D Schmidt; R Christopher Pierce
Journal:  Neuropsychopharmacology       Date:  2017-12-12       Impact factor: 7.853

Review 5.  The tetrapartite synapse: Extracellular matrix remodeling contributes to corticoaccumbens plasticity underlying drug addiction.

Authors:  Alexander C W Smith; Michael D Scofield; Peter W Kalivas
Journal:  Brain Res       Date:  2015-03-30       Impact factor: 3.252

Review 6.  Integrating synaptic plasticity and striatal circuit function in addiction.

Authors:  Brad A Grueter; Patrick E Rothwell; Robert C Malenka
Journal:  Curr Opin Neurobiol       Date:  2011-10-12       Impact factor: 6.627

Review 7.  Using metabotropic glutamate receptors to modulate cocaine's synaptic and behavioral effects: mGluR1 finds a niche.

Authors:  Jessica A Loweth; Kuei Y Tseng; Marina E Wolf
Journal:  Curr Opin Neurobiol       Date:  2013-02-04       Impact factor: 6.627

8.  Different roles of BDNF in nucleus accumbens core versus shell during the incubation of cue-induced cocaine craving and its long-term maintenance.

Authors:  Xuan Li; M R DeJoseph; Janice H Urban; Amine Bahi; Jean-Luc Dreyer; Gloria E Meredith; Kerstin A Ford; Carrie R Ferrario; Jessica A Loweth; Marina E Wolf
Journal:  J Neurosci       Date:  2013-01-16       Impact factor: 6.167

9.  A protein synthesis-dependent mechanism sustains calcium-permeable AMPA receptor transmission in nucleus accumbens synapses during withdrawal from cocaine self-administration.

Authors:  Andrew F Scheyer; Marina E Wolf; Kuei Y Tseng
Journal:  J Neurosci       Date:  2014-02-19       Impact factor: 6.167

Review 10.  The AMPA Receptor Code of Synaptic Plasticity.

Authors:  Graham H Diering; Richard L Huganir
Journal:  Neuron       Date:  2018-10-24       Impact factor: 17.173

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.